1. Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
    Young-Sun Lee et al, 2016, Mediators of Inflammation CrossRef
  2. Intra-islet glucagon-like peptide 1
    Genevieve E. Fava et al, 2016, Journal of Diabetes and its Complications CrossRef
  3. Differential effects of angiotensin receptor blockers on pancreatic islet remodelling and glucose homeostasis in diet-induced obese mice
    Francielle Graus-Nunes et al, 2017, Molecular and Cellular Endocrinology CrossRef
  4. Activation of ACE2/angiotensin (1–7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model
    Xiuping Xuan et al, 2017, Metabolism CrossRef
  5. Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome
    Maarja Toots et al, 2018, Sci Rep CrossRef
  6. Liraglutide Ameliorates β-Amyloid Deposits and Secondary Damage in the Ipsilateral Thalamus and Sensory Deficits After Focal Cerebral Infarction in Rats
    Hui-Li Zhu et al, 2018, Front. Neurosci. CrossRef
  7. null
    Fernando Suarez-Sanchez et al, 2019 CrossRef
  8. G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
    Darren M. Riddy et al, 2018, Pharmacol Rev CrossRef
  9. New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling
    Alejandra Tomas et al, 2019, Journal of Molecular Biology CrossRef
  10. Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes
    Habib Yaribeygi et al, 2020, Life Sciences CrossRef
  11. Early protein restriction increases intra-islet GLP-1 production and pancreatic β-cell proliferation mediated by the β-catenin pathway
    Chaiane Aline da Rosa-Santos et al, 2020, Eur J Nutr CrossRef
  12. Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
    Alina Kuryłowicz et al, 2020, Molecules CrossRef
  13. A GLP‑1 receptor agonist attenuates human islet amyloid polypeptide‑induced autophagy and apoptosis in MIN6 cells
    Xiong Chen et al, 2018, Mol Med Report CrossRef
  14. Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin.
    Anna Vanderheiden et al, 2016, J Clin Endocrinol Metab CrossRef
  15. Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1/M2 phenotype macrophage in db/db mice
    Yanming Wang et al, 2020, Pharmacological Research CrossRef
  16. Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study
    Tao Tao et al, 2020 CrossRef
  17. Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies
    Safia Costes et al, 2021, IJMS CrossRef
  18. The role of incretins and incretin-based drugs in autoimmune diseases
    Shabnam Radbakhsh et al, 2021, International Immunopharmacology CrossRef
  19. GLP-2 Is Locally Produced From Human Islets and Balances Inflammation Through an Inter-Islet-Immune Cell Crosstalk
    Wei He et al, 2021, Front. Endocrinol. CrossRef
  20. Berberine Reshapes the Balance of the Local Renin-Angiotensin System by Modulating Autophagy under Metabolic Stress in Pancreatic Islets
    Chenghu Huang et al, 2021, Journal of the Renin-Angiotensin-Aldosterone System CrossRef
  21. The Impact of Incretin-Based Medications on Lipid Metabolism
    Habib Yaribeygi et al, 2021, Journal of Diabetes Research CrossRef
  22. Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review
    Xie Lingli et al, 2022, Life Sciences CrossRef
  23. Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases.
    Eloisa Martins da Silva et al, 2022, Peptides CrossRef
  24. Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
    Marlena M. Holter et al, 2022, Front. Endocrinol. CrossRef
  25. Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats
    Ananyaa Sridhar et al, 2022, PLoS ONE CrossRef
  26. Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
    Sonalika Bhalla et al, 2022, Neuroscience & Biobehavioral Reviews CrossRef
  27. Antidiabetic Drugs and their Potential Use in COVID-19: A Mechanistic Approach
    Bryan Alejandro Espinosa-Rodriguez et al, 2023, EMIDDT CrossRef
  28. The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
    Ana Petrovic et al, 2023, CIMB CrossRef
  29. null
    Laith Hattar et al, 2023 CrossRef
  30. null
    Fernando Suárez-Sánchez et al, 2023 CrossRef
  31. Development of Syringaldehyde as an Agonist of the GLP-1 Receptor to Alleviate Diabetic Disorders in Animal Models
    Jenpei Lee et al, 2024, Pharmaceuticals CrossRef
  32. Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed mice
    Ananyaa Sridhar et al, 2024, Peptides CrossRef